drugset / Trial / NCT03464305
ASPIRIN Trial Belgium
Phase 3
Active not recruiting
148 enrolled
University Hospital, Antwerp
Anticancerfund · collabKom Op Tegen Kanker · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether acetylsalicylic acid is effective on the recurrence and survival of colon cancer patients.
Timeline
- Start
- 2018-02-22
- Primary completion
- 2027-12-31
- Completion
- 2027-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aspirin | Small molecule | 80 mg | Oral |